Old Tricks In New Designs: Part D Increasing Commercial Plan Design Options
Executive Summary
Medicare Part D is giving drug plans an opportunity to use more restrictive pharmacy benefit designs that had previously not been palatable to the commercial sector
You may also be interested in...
Merck Pushes Discount Zocor; Health Plans Are Wary, But Pfizer Is Concerned
The mixed response to Merck's efforts to reach rebate agreements with health plans to place brand Zocor on the lowest cost-sharing tiers of their formularies suggests it is unlikely such a strategy would be broadly adopted by brand firms going forward
Merck Pushes Discount Zocor; Health Plans Are Wary, But Pfizer Is Concerned
The mixed response to Merck's efforts to reach rebate agreements with health plans to place brand Zocor on the lowest cost-sharing tiers of their formularies suggests it is unlikely such a strategy would be broadly adopted by brand firms going forward
Lifestyle Drugs Require High Copay Differentials to Curb Use, PBM Exec Says
A high level of cost sharing is necessary to discourage non-essential use of drugs, Catalyst Rx President Kevin Hooks said